Thomas Strüngmann

ATS Beteiligungsverwaltung GmbH (ATS Beteiligungsverwaltung) is an independent German private equity firm which is headquartered in Munich and was founded in 2006 by Andreas and Thomas Strüngmann, offering their know-how and strategic support to selected biotech companies.

Klinge Pharma GmbH is a pharmaceutical company based in Holzkirchen, Germany. Klinge Pharma's mission is to innovate and improve upon traditional pharmaceutical practices. The German company's description emphasizes their commitment to doing things better and their belief that innovation and tradition go hand in hand. The private company was founded in 1933 by A. Klinge and is currently led by CEOs Thomas Strüngmann, Fabian Strüngmann, and Ines Bohn.

Klinge Pharma GmbH manufactures pharmaceutical products. It offers Binko, Utipro plus, Venostasin, Andvomex A. The company was founded in 1933 and is headquartered in Holzkirchen, Germany.

Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier.

Projektgesellschaft St. Anna 16 mbH is a German company that provides financial services. The private company is based in Unterfoehring, Germany. The CEOs of the company are Thomas Strüngmann, Stefan Legat.

Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany.

Santo Holding AG operates as a holding company with interest in providing investments services. The firm provides loans, operating leases and acquires, holds, and sells real estate property. It invests in biotechnology, pharmaceuticals, life sciences, and healthcare companies. The company was founded in 2001 and is headquartered in Zurich, Switzerland.

AT Newtec GmbH provides investment and management services. The firm’s investment operations focus on businesses engaged in the biotechnology research and development sector. The company was founded by Andreas Strungmann and Thomas Strungmann is headquartered in Munich, Germany.